| 
|  | WZ3146Description of:WZ3146WZ3146 has a basic chemical framework (covalent pyrimidine) which is different from that of other EGFR inhibitors.This ag...
 更多>> |  | 
| 
|  | WZ4002Description of:WZ4002WZ4002 has a basic chemical framework (covalent pyrimidine) which is different from that of other EGFR inhibitors. [1]
 更多>> |  | 
| 
|  | WZ8040Description of:WZ8040WZ8040 is an irreversiblely inhibitor against EGFR T790M (mutation of the gatekeeper T790 residue) which is detected in 5...
 更多>> |  | 
| 
|  | PF299804|達(dá)克替尼Description of:PF299804PF299804 is a quinazalone-based irreversible pan-ERBB inhibitor structurally related to CI-1033. PF299804 is a potent i...
 更多>> |  | 
| 
|  | PD153035Description of:PD153035An extremely potent inhibitor of epidermal growth factor (EGF) receptor tyrosine kinase, with an IC50 of 25 pM. Inhibit...
 更多>> |  | 
| 
|  | Pelitinib(EKB-569)|培利替尼Description of:Pelitinib(EKB-569)Pelitinib is a 3-cyanoquinoline pan-ErbB tyrosine kinase inhibitor with potential antineoplastic activity. Pe...
 更多>> |  | 
| 
|  | 來那替尼|Neratinib(HKI-272)Description of:Neratinib(HKI-272)來那替尼Neratinib binds to the HER-2 receptor irreversibly, thereby reducing autophosphorylation in cells, appare...
 更多>> |  | 
| 
|  | LapatinibDescription of:LapatinibLapatinib (GW572016) is a selective inhibitor of both epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinas...
 更多>> |  |